JP2022547888A5 - - Google Patents

Info

Publication number
JP2022547888A5
JP2022547888A5 JP2022514677A JP2022514677A JP2022547888A5 JP 2022547888 A5 JP2022547888 A5 JP 2022547888A5 JP 2022514677 A JP2022514677 A JP 2022514677A JP 2022514677 A JP2022514677 A JP 2022514677A JP 2022547888 A5 JP2022547888 A5 JP 2022547888A5
Authority
JP
Japan
Prior art keywords
formula
nucleotide
group
double
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022514677A
Other languages
English (en)
Japanese (ja)
Other versions
JP7667775B2 (ja
JP2022547888A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/074800 external-priority patent/WO2021044004A1/en
Publication of JP2022547888A publication Critical patent/JP2022547888A/ja
Publication of JP2022547888A5 publication Critical patent/JP2022547888A5/ja
Application granted granted Critical
Publication of JP7667775B2 publication Critical patent/JP7667775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022514677A 2019-09-05 2020-09-04 ヌクレオチド類似体を含有するオリゴヌクレオチド Active JP7667775B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19195696.0 2019-09-05
EP19195696 2019-09-05
PCT/EP2020/074800 WO2021044004A1 (en) 2019-09-05 2020-09-04 Oligonucleotides containing nucleotide analogs

Publications (3)

Publication Number Publication Date
JP2022547888A JP2022547888A (ja) 2022-11-16
JP2022547888A5 true JP2022547888A5 (cg-RX-API-DMAC7.html) 2025-01-08
JP7667775B2 JP7667775B2 (ja) 2025-04-23

Family

ID=67874384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514677A Active JP7667775B2 (ja) 2019-09-05 2020-09-04 ヌクレオチド類似体を含有するオリゴヌクレオチド

Country Status (5)

Country Link
US (1) US20220372063A1 (cg-RX-API-DMAC7.html)
EP (1) EP4025582A1 (cg-RX-API-DMAC7.html)
JP (1) JP7667775B2 (cg-RX-API-DMAC7.html)
CN (1) CN114728999A (cg-RX-API-DMAC7.html)
WO (1) WO2021044004A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112105625B (zh) 2018-03-07 2024-12-31 赛诺菲 核苷酸前体、核苷酸类似物以及含其的寡聚化合物
CN113166760A (zh) 2018-11-23 2021-07-23 赛诺菲 用于抑制angptl8的新型rna组合物和方法
CA3226457A1 (en) * 2021-07-30 2023-02-02 Amy WALKER Nanoparticles and peptides for the delivery of cargos to muscle cells
CN119451971A (zh) * 2022-06-27 2025-02-14 大睿生物医药科技(上海)有限公司 具有增强的稳定性的核苷酸替代物
JP2025532985A (ja) 2022-09-30 2025-10-03 アルナイラム ファーマシューティカルズ, インコーポレイテッド 修飾二本鎖rna剤
WO2025031479A1 (zh) * 2023-08-10 2025-02-13 大睿生物 含有核苷酸类似物的双链rna
AU2024360473A1 (en) * 2023-11-06 2026-06-04 Hangzhou Tianlong Pharmaceutical Co., Ltd. Modification template for improving inhibitory effect of double-stranded oligonucleotide on target gene, combination thereof and use thereof
CN118994133A (zh) * 2023-12-08 2024-11-22 浙江大学 基于无保护扩环策略的吗啉代核苷单体全流程合成工艺
WO2025240414A1 (en) * 2024-05-14 2025-11-20 Sri International Cardiomyocyte-specific molecular guidance system peptides and uses thereof
TW202617993A (zh) * 2024-06-26 2026-05-01 大陸商上海拓界生物醫藥科技有限公司 雙環結構及包含其的寡核苷酸
TW202619721A (zh) * 2024-09-18 2026-05-16 美商美國禮來大藥廠 製備用於rna合成之亞磷醯胺化物之改良化學方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166315A (en) 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US5185444A (en) 1985-03-15 1993-02-09 Anti-Gene Deveopment Group Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5665710A (en) 1990-04-30 1997-09-09 Georgetown University Method of making liposomal oligodeoxynucleotide compositions
US5432272A (en) 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
CA2135646A1 (en) 1992-05-11 1993-11-25 Kenneth G. Draper Method and reagent for inhibiting viral replication
US5977343A (en) 1992-05-14 1999-11-02 Ribozyme Pharmaceuticals, Inc. Synthesis, deprotection, analysis and purification of RNA and ribozymes
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
WO1996005298A1 (en) * 1994-08-09 1996-02-22 Ciba-Geigy Ag Antitumor antisense oligonucleotides
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5889136A (en) 1995-06-09 1999-03-30 The Regents Of The University Of Colorado Orthoester protecting groups in RNA synthesis
US20050032069A1 (en) * 2002-11-05 2005-02-10 Muthiah Manoharan Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation
US6001311A (en) 1997-02-05 1999-12-14 Protogene Laboratories, Inc. Apparatus for diverse chemical synthesis using two-dimensional array
US6054576A (en) 1997-10-02 2000-04-25 Ribozyme Pharmaceuticals, Inc. Deprotection of RNA
US6111086A (en) 1998-02-27 2000-08-29 Scaringe; Stephen A. Orthoester protecting groups
CA2326823A1 (en) 1998-04-20 1999-10-28 Ribozyme Pharmaceuticals, Inc. Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
ATE237312T1 (de) 1998-07-20 2003-05-15 Protiva Biotherapeutics Inc In liposomen verkapselte nukleinsäurekomplexe
US6995259B1 (en) 1998-10-23 2006-02-07 Sirna Therapeutics, Inc. Method for the chemical synthesis of oligonucleotides
ATE506372T1 (de) 2000-09-01 2011-05-15 Ribozyme Pharm Inc Verfahren zur herstellung von nukleosidderivate
MXPA03006514A (es) 2001-01-22 2004-12-02 Merck & Co Inc Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico.
US7205399B1 (en) 2001-07-06 2007-04-17 Sirna Therapeutics, Inc. Methods and reagents for oligonucleotide synthesis
US6989442B2 (en) 2002-07-12 2006-01-24 Sirna Therapeutics, Inc. Deprotection and purification of oligonucleotides and their derivatives
NZ580712A (en) * 2007-05-22 2011-12-22 Marina Biotech Inc Hydroxymethyl substituted rna oligonucleotides and rna complexes containing acyclic monomers
WO2014113540A1 (en) * 2013-01-16 2014-07-24 Iowa State University Research Foundation, Inc. A deep intronic target for splicing correction on spinal muscular atrophy gene
TWI726844B (zh) * 2014-05-23 2021-05-11 美商健臻公司 胜肽載體上之多重寡核苷酸部分
KR102410072B1 (ko) * 2014-08-29 2022-06-20 알닐람 파마슈티칼스 인코포레이티드 트랜스타이레틴(ttr) 매개 아밀로이드증의 치료 방법
US20160186174A1 (en) 2014-12-29 2016-06-30 Ionis Pharmaceuticals, Inc. Substituted morpholino compounds analogs thereof and oligomeric compounds prepared therefrom
MA41795A (fr) * 2015-03-18 2018-01-23 Sarepta Therapeutics Inc Exclusion d'un exon induite par des composés antisens dans la myostatine
WO2018013999A1 (en) * 2016-07-15 2018-01-18 Am Chemicals Llc Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis
CN112105625B (zh) * 2018-03-07 2024-12-31 赛诺菲 核苷酸前体、核苷酸类似物以及含其的寡聚化合物
CN113166760A (zh) * 2018-11-23 2021-07-23 赛诺菲 用于抑制angptl8的新型rna组合物和方法
CN115176011B (zh) * 2019-08-27 2025-11-11 赛诺菲 用于抑制pcsk9的组合物和方法

Similar Documents

Publication Publication Date Title
JP2022513111A5 (cg-RX-API-DMAC7.html)
JP2021517126A5 (cg-RX-API-DMAC7.html)
JP2019530656A5 (cg-RX-API-DMAC7.html)
JP2019526555A5 (cg-RX-API-DMAC7.html)
CA3032165C (en) Compositions comprising reversibly modified oligonucleotides and uses thereof
JP2022546040A5 (cg-RX-API-DMAC7.html)
JP2023536320A5 (cg-RX-API-DMAC7.html)
ES2924806T3 (es) Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo
JP2023523130A5 (cg-RX-API-DMAC7.html)
JP2022505234A5 (cg-RX-API-DMAC7.html)
JP2005533835A5 (cg-RX-API-DMAC7.html)
JP2003513015A5 (cg-RX-API-DMAC7.html)
FI4426270T3 (fi) Lipidi-nanopartikkelit oligonukleotidien kuljetusta varten
JP2022534702A5 (cg-RX-API-DMAC7.html)
IL316808A (en) Modified double-stranded RNA materials and their uses
JP2011509949A5 (cg-RX-API-DMAC7.html)
JP2024530956A5 (cg-RX-API-DMAC7.html)
JP2016533761A5 (cg-RX-API-DMAC7.html)
US11591362B2 (en) Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides
JP2010521471A5 (cg-RX-API-DMAC7.html)
JP7138349B2 (ja) 核酸化合物およびオリゴヌクレオチド
JP2022533421A5 (cg-RX-API-DMAC7.html)
JP2022545101A5 (cg-RX-API-DMAC7.html)
WO2008077600B1 (en) Compounds and methods for synthesis and purification of oligonucleotides
JPWO2021049504A5 (cg-RX-API-DMAC7.html)